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Summary
Background:  Previous  studies  comparing  proximal  femoral  nail  antirotation  (PFNA)  with
dynamic hip  screw  (DHS)  for  peritrochanteric  fractures  reported  conﬂicting  ﬁndings.  The
objective of  this  meta-analysis  was  to  compare  the  efﬁcacy  and  safety  of  PFNA  and  DHS  for
pertrochanteric  fractures.
Hypothesis:  PFNA  achieves  better  efﬁcacy  for  peritrochanteric  fractures  compared  with  DHS.
Materials and  methods:  Relevant  randomized  controlled  trials  comparing  PFNA  with  DHS  for
pertrochanteric  fractures  were  assessed  for  eligibility  and  included  into  this  meta-analysis.  Data
were extracted  independently  and  methodological  quality  was  further  assessed.  The  inclusion
criteria of  this  meta-analysis  were:  randomized  controlled  trials  comparing  PFNA  with  DHS
for pertrochanteric  fractures  and  reporting  at  least  one  of  these  main  outcomes,  including
operating time,  blood  loss,  all  causes  mortality,  and  complications.
Results:  Five  randomized  controlled  trials  were  ﬁnally  included  into  this  meta-analysis.  Pooled
results showed  there  were  less  blood  loss  (weighted  mean  difference  Blood  loss  =  −249.75  ml,
95%CI −303.83  to  −195.67,  P  <  0.0001)  and  fewer  complications  (Odds  ratio  =  0.40,  95%CI  0.23
to 0.70,  P  =  0.001)  in  the  PFNA  group  compared  with  the  DHS  group.  However,  there  was  no  dif-
ference in  term  of  mortality  between  those  two  groups  (Odds  ratio  mortality  =  1.13,  95%CI  0.47
to 2.69,  P  =  0.79).  Sensitivity  analysis  by  sequential  omission  of  individual  studies  showed  that
the signiﬁcance  of  pooled  odds  ratios  was  robust,  which  suggested  this  outcome  was  credible.
Discussion:  PFNA  can  beneﬁt  peritrochanteric  fractures  patients  with  less  blood  loss  and  fewer
complications  compared  with  DHS.  The  signiﬁcant  heterogeneity  among  the  included  trials  for
intraoperative  blood  loss,  and  operation  time  may  be  attributable  to  variation  in  the  skills  of
the surgeons  and  the  different  types  of  perirochanteric  fractures.  In  addition,  more  powered
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randomized  studies  are  needed  to  identify  the  ﬁndings  from  this  meta-analysis,  and  the  effects
of long-term  follow-up  also  need  further  study,  especially  the  impact  on  the  mortality.
Level of  evidence:  Level  II,  meta-analysis  of  low  powered  randomized  study.
© 2013  Elsevier  Masson  SAS.  All  rights  reserved.
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eritrochanteric  fractures  are  becoming  increasingly  com-
on  as  our  population  ages.  These  fractures  typically  occur
n  elderly  patients  and  often  result  in  the  end  of  the
atient’s  functional  independence  [1,2].  Treatment  of  per-
trochanteric  fracture  is  based  on  patient  medical  condition,
one  quality  and  the  biomechanics  of  the  fracture  conﬁgu-
ation.  Effective  treatment  strategies  resulting  in  high  rates
f  union  of  these  fractures  and  low  rates  of  complications
re  important.  Generally,  dynamic  hip  screw  (DHS)  internal
xation  is  one  of  the  most  primary  options  [3,4].  For  sta-
le  or  minimally  displaced  peritrochanteric  fractures,  the
HS  ﬁxation  produces  reproducibly  reliable  results.  How-
ver,  in  unstable  fractures,  the  DHS  device  performs  less
ell  with  a  relatively  higher  incidence  of  internal  ﬁxa-
ion  failure  [3,4].  The  proximal  femoral  nail  antirotation
PFNA)  is  an  intramedullary  device  with  a  helical  blade
ather  than  a  screw  for  better  purchase  in  the  femoral
ead  and  has  been  adopted  for  patients  with  unstable  per-
trochanteric  fractures  [5—7].  There  were  many  studies
omparing  the  outcomes  of  the  PFNA  and  DHS  for  per-
trochanteric  fractures,  but  there  was  obvious  inconsistency
f  effects  across  those  studies  and  the  optimal  manage-
ent  of  peritrochanteric  fractures  remained  controversial
8—10].  Single  studies  with  small  sample  size  have  various
esigns,  different  methodologies  and  insufﬁcient  power,  and
ail  to  get  a  precise  estimate,  while  combining  data  from
ll  eligible  studies  by  meta-analysis  has  the  advantage  of
educing  random  error  and  obtaining  precise  estimates  for
linical  interventions.  Thus,  to  provide  the  most  compre-
ensive  assessment  of  the  PFNA  and  DHS  for  peritrochanteric
ractures,  we  performed  this  meta-analysis  based  on  all  rele-
ant  randomized  controlled  trials  comparing  PFNA  with  DHS
or  peritrochanteric  fractures.  The  hypothesis  of  present
tudy  was  that  PFNA  achieved  better  efﬁcacy  for  per-
trochanteric  fractures  compared  with  DHS.
ethods
earch  strategy  and  eligibility  criteria
e  searched  PubMed,  Embase,  and  China  National  Knowl-
dge  Infrastructure  (CNKI)  databases  for  randomized  con-
rolled  trials  comparing  PFNA  with  DHS  for  peritrochanteric
ractures  (last  update  October  2011).  We  used  the  fol-
owing  search  terms:  (‘‘PFNA’’  or  ‘‘proximal  femoral  nail
ntirotation’’)  and  (‘‘DHS’’  or  ‘‘dynamic  hip  screw’’)  and
‘‘peritrochanteric  fractures’’  or  ‘‘intertrochanteric  frac-
ures’’  or  ‘‘subtrochanteric  fractures’’  or  ‘‘pertrochanteric
ractures’’  or  ‘‘extracapsular  hip  fractures’’).  The  ref-
rences  of  the  retrieved  articles  were  also  conﬁrmed.
c
c
p
sanguage  restriction  was  not  imposed  in  our  search.
he  inclusion  criteria  of  this  meta-analysis  were:  ran-
omized  controlled  trials  comparing  PFNA  with  DHS  for
eritrochanteric  fractures  and  reporting  at  least  one  of  the
ain  outcomes,  including  operating  time,  blood  loss,  all
auses  mortality,  and  complications.  The  major  reasons  for
xclusion  from  the  study  were:
 case  series  that  investigated  either  PFNA  or  DHS  for  treat-
ing  peritrochanteric  fractures;
 data  were  duplicated;
 demographic  background  of  the  patients  and  preoperative
conditions  were  not  similar;
 and  usable  data  were  not  reported.  Inconsistencies  were
resolved  by  reaching  a consensus  between  all  authors
after  discussion.
ata  extraction  and  quality  assessment
he  following  information  was  extracted  from  each  study:
ear  of  publication,  study  design,  number  of  patients,  frac-
ure  classiﬁcation,  average  follow-up  time,  operating  time,
lood  loss,  all  causes  mortality,  and  complications.  We  also
id  some  contacts  with  the  authors  of  the  retained  papers  to
mprove  data  extraction.  The  complications  mainly  included
he  postoperative  complications.  The  quality  of  random-
zed  controlled  trials  included  into  this  meta-analysis  was
ssessed  by  the  Jadad  score  [11].  The  Jadad  score  system
as  as  follows:
 was  the  study  described  as  randomized?
 was  the  study  described  as  double  blind?
 was  there  a  description  of  withdrawals  and  dropouts?  [11].
Randomized  controlled  trials  with  scores  no  less  than
hree  points  were  deﬁned  as  high  quality  randomized  con-
rolled  trials,  while  randomized  controlled  trials  with  scores
ess  than  three  points  were  deﬁned  as  lesser  quality  random-
zed  controlled  trials  [11].  However,  we  did  not  undertake  a
ubgroup  analysis  for  different  fracture  types  because  few
ncluded  studies  described  the  subgroup  data  by  fracture
ypes.
tatistical  analysis
n  each  study  the  pooled  odds  ratio  (OR)  with  a  95%
onﬁdence  interval  (CI)  was  calculated  for  dichotomous  out-
omes,  and  weighted  mean  difference  (WMD)  with  a  95%
onﬁdence  interval  (CI)  was  calculated  for  continuous  out-
omes.  To  assess  the  between-study  heterogeneity  more
recisely,  both  the  Chi2 based  Q  statistic  test  (Cochran’s  Q
tatistic)  [12]  to  test  for  heterogeneity  and  the  I2 statistic
ures  379
75 record s identif ied through 
databases
1 re cord ident ifie d 
through ot her  so urces
76 potent ial records  screen ed
61 re cor ds  excluded (10  Anima l 
studies, 35 non-comparison studies, 
and 16 reviews)
15 full-text articles assessed for 
eligibi lity
5 Randomized controlled trials
included  into this  meta-anal ysis
10 full -text articles exc luded
7 Non -random studies
2 irrelevant stud ies
1 study withou t data
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to  quantify  the  proportion  of  the  total  variation  attributable
to  heterogeneity  were  calculated  [13].  A  signiﬁcance  level
of  less  than  0.10  for  the  Chi2 test  was  interpreted  as
evidence  of  heterogeneity.  When  there  was  no  statistical
evidence  of  heterogeneity,  a  ﬁxed  effect  model  was  adopted
[14];  otherwise,  a  random  effect  model  was  chosen  [15].
Besides,  to  validate  the  credibility  of  outcomes  in  this  meta-
analysis,  a  sensitivity  analysis  was  performed  by  sequential
omission  of  individual  studies  [16].  Publication  bias  was
investigated  by  funnel  plot  and  an  asymmetric  plot  sug-
gested  possible  publication  bias  [17].  Statistical  analyses
were  performed  with  the  software  program  RevMan  (Ver-
sion  5.0,  Copenhagen:  The  Nordic  Cochrane  Centre,  the
Cochrane  Collaboration).  All  P-values  were  two-sided  and
a  P-value  of  less  than  0.05  was  deemed  statistically  signiﬁ-
cant.
Results
Study  characteristics
There  were  76  initial  records  identiﬁed  (Fig.  1).  A  total
of  61  of  these  records  were  excluded,  leaving  15  poten-
tially  relevant  studies  [8—10,18—29].  We  then  excluded
seven  non-random  studies  [20—26],  two  irrelevant  stud-
ies  [18,19]  and  one  studies  for  no  available  data  [27].
Finally,  ﬁve  randomized  controlled  trials  were  included  into
this  meta-analysis  (Fig.  1,  Table  1)  [8—10,28,29].  Table  1
summarized  the  main  characteristics  of  the  included  stud-
ies.  Table  2  showed  the  methodological  quality  of  included
studies  in  this  meta-analysis  (Table  2).  The  quality  of  ran-
domized  controlled  trials  included  was  assessed  using  the
Jadad  scoring  system,  and  three  trials  were  high  quality
randomized  controlled  trials  with  scores  no  less  than  three
points.
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Table  1  Main  characteristics  of  the  studies  included  into  the  me
Study  [Reference]  Study
designa
Indication  DFNA  gr
age,  sex
Garg  et  al.  [10]  RCT  Unstable
trochanteric
fractures  (31A2-3)
42  patie
years,  3
Wang et  al.  [28]  RCT  Intertrochanteric
fractures  (Evans  I-
IV)
66  patie
years,  2
Xu et  al.  [9] RCT  Unstable
pertrochanteric
fractures  (31A2-3)
51  patie
years,  1
Zou et  al.  [8]  RCT  Trochanteric
Fractures  (31A1-3)
58  patie
12  males
Zuo et  al.  [29]  RCT  Intertrochanteric
fractures  (Evans
I—IV)
26  patie
10  male
DFNA: proximal femoral nail antirotation; DHS: dynamic hip screw.
a RCT was for randomized controlled trial.igure  1  Flow  chart  demonstrating  selection  of  studies  for
nclusion  in  the  meta-analysis.
peration  time  and  blood  loss
ata  for  operation  time  were  reported  in  4  trials  (Table  3,
ig.  2A).  There  was  signiﬁcant  heterogeneity  among  these
rials  (I2 =  99%,  P  <  0.001),  and  the  random  effects  model  was
sed  to  pool  the  results.  Meta-analyses  showed  that  PFNA
as  marginally  associated  with  shorter  operation  time  com-
ared  with  DHS  (WMDOperation time =  −29.53  minutes,  95%CI
62.53  to  3.46,  P  =  0.08)  (Fig.  2A).  Besides,  sensitivity  anal-
sis  by  sequential  omission  of  individual  studies  showed  the
igniﬁcance  of  WMDOperation time was  not  robust,  which  sug-
ested  this  outcome  was  not  credible.
ta-analysis.
oup  (Mean
 distribution)
DHS  group  (Age,
sex  distribution)
Follow-up  (Mean
duration,  months)
nts  (60.2
2  males)
39  patients  (64.3
years,  27  males)
40  months  (36  to
48  months)
nts  (80.0
1  males)
71  patients  (80.8
years,  25  males)
18  months
nts  (69.9
8  males)
55  patients  (68.6
years,  15  males)
15  months  (12  to
24  months)
nts  (65  years,
)
63  patients
(65  years,
15  males)
12  months
nts  (68  years,
s)
63  patients  (66
years,  11  males)
18  months  (12  to
24  months)
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Table  2  Methodological  quality  of  included  studies  in  this  meta-analysis.
Study  [Reference]  Randomization  Allocation
concealment
Blinding  Loss  to
follow-up
Jadad
score
Baseline
Age  Gender  Fracture  type
Garg  et  al.  [10]  Adequate  Unclear  Unclear  Yes  4  Comparable  Comparable  Comparable
Wang et  al.  [28]  Inadequate  Unclear  Unclear  Yes  2  Comparable  Comparable  Comparable
Xu et  al.  [9]  Adequate  Unclear  Unclear  Yes  4  Comparable  Comparable  Comparable
Zou et  al.  [8]  Inadequate  Unclear  Unclear  Yes  2  Comparable  Comparable  Comparable
Zuo et  al.  [29]  Adequate  Unclear  Unclear  Yes  4  Comparable  Comparable  Comparable
Table  3  Summary  of  meta-analysis  of  comparing  PFNA  with  DHS  for  peritrochanteric  fractures.
Comparison  items  Number  of
included
studies
WMD  or  odds  ratio  Heterogeneity  Model
WMD/OR  (95%CI)  P-value  I2 (%)  PH
Operating  time  4  −29.53  (−62.53  to  3.46)  0.08  99  <  0.001  Random
Blood loss  4  −249.75  (−303.83  to  −195.67)  <  0.001  89  <  0.001  Random
Complications  5  0.50  (0.33  to  0.76)  0.001  23  0.27  Fixed
Mortality 3  1.13  (0.47  to  2.69)  0.79  0  0.57  Fixed
 aver
 I2: t
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vPH: the P-value of heterogeneity analysis; WMD  correspond to the
pooled estimates; OR: odds ratio; 95%CI: 95% conﬁdence interval;
Data  for  blood  loss  were  reported  in  4  trials  (Table  3,
ig.  2B).  There  was  also  signiﬁcant  heterogeneity  among
hese  trials  (I2 =  96%,  P  <  0.0001),  and  the  random  effects
odel  was  used  to  pool  the  results.  Meta-analyses  showed
hat  there  was  obvious  less  blood  loss  in  the  PRFA  group
P
t
W
a
igure  2  Forest  plot  of  pooled  WMD  with  95%  CI  for  comparing  PFN
perating outcomes.  A.  Forest  plot  of  pooled  WMD  with  95%  CI  on  th
ith 95%  CI  on  the  assessment  of  blood  loss  (The  size  of  the  data  ma
ertical broken  line  represent  the  summary  estimate).age of PFNA minus the average of DHS; P-value: the value of the
he value of I2 statistic.
WMDBlood loss =  −249.75  ml,  95%CI  −303.83  to  −195.67,
 <  0.0001)  (Fig.  2B).  Besides,  sensitivity  analysis  by  sequen-
ial  omission  of  individual  studies  showed  the  signiﬁcance  of
MDBlood loss was  robust,  which  suggested  this  outcome  was
lso  credible.
A  with  DHS  for  peritrochanteric  fractures  on  the  assessment  of
e  assessment  of  operation  time.  B.  Forest  plot  of  pooled  WMD
rker  corresponds  to  the  weight  of  the  study.  The  diamond  and
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Figure  3  Forest  plot  of  pooled  OR  with  95%  CI  for  comparing  PFNA  with  DHS  for  peritrochanteric  fractures  on  the  assessment  of
complications  (The  size  of  the  data  marker  corresponds  to  the  weight  of  the  study.  The  diamond  and  vertical  broken  line  represent
the summary  estimate).
Figure  4  Forest  plot  of  pooled  OR  with  95%  CI  for  comparing  PFNA  with  DHS  for  peritrochanteric  fractures  on  the  assessment  of
t  of  the  study.  The  diamond  and  vertical  broken  line  represent  the
Figure  5  Funnel  plot  to  assess  publication  bias  in  the  meta-
analysis  of  for  comparing  PFNA  with  DHS  for  peritrochanteric
fractures  on  the  assessment  of  complications  (The  symmetry  of
F
r
T
n
Dmortality (The  size  of  the  data  marker  corresponds  to  the  weigh
summary estimate).
Complications  evaluation
Data  for  complications  were  reported  in  all  5 trials  (Table  3,
Fig.  3).  There  was  no  signiﬁcant  heterogeneity  between  the
trials  (I2 =  23%,  P  =  0.27),  and  the  ﬁxed  effects  model  was
used  to  pool  the  results.  Meta-analyses  showed  that  there
was  fewer  complications  in  the  PFNA  group  compared  with
the  DHS  group  (OR  =  0.40,  95%CI  0.23  to  0.70,  P  =  0.001)
(Fig.  3).  Sensitivity  analysis  by  sequential  omission  of  indi-
vidual  studies  showed  the  signiﬁcance  of  OR  was  robust,
which  suggested  this  outcome  was  also  credible.
Mortality  evaluation
Data  for  mortality  for  any  cause  were  reported  in  only
three  trials  (Fig.  4).  We  noted  no  signiﬁcant  heterogeneity
between  the  trials  (I2 =  0%,  P  =  0.57),  and  the  ﬁxed  effects
model  was  used  to  pool  the  results.  Meta-analysis  showed
that  there  was  no  difference  in  term  of  the  prognosis
between  those  two  groups  (OR Mortality =  1.13,  95%CI  0.47  to
2.69,  P  =  0.79)  (Fig.  4).  Sensitivity  analysis  by  sequential
omission  of  individual  studies  showed  the  signiﬁcance  of  OR
was  robust,  which  suggested  this  outcome  was  credible.
Assessment  of  publication  biasFunnel  plot  was  performed  to  assess  the  publication  bias  in
this  meta-analysis.  The  symmetry  of  Funnel  plots’  shape  did
not  ﬁnd  obvious  evidence  of  publication  bias  risk  (Fig.  5).
T
a
i
munnel  plot’  shape  did  not  show  evidence  of  publication  bias
isk).
hus,  the  results  above  suggested  that  publication  bias  was
ot  evident  in  this  meta-analysis.
iscussionhere  are  many  studies  comparing  the  outcomes  of  the  PFNA
nd  DHS  for  peritrochanteric  fractures,  but  there  is  obvious
nconsistency  of  effects  across  those  studies  and  the  opti-
al  management  of  peritrochanteric  fractures  remained
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ontroversial  [8—10,18—31].  Thus,  to  provide  the  most
omprehensive  assessment  of  the  PFNA  and  DHS  for  per-
trochanteric  fractures,  we  performed  this  meta-analysis  by
ncluding  ﬁve  randomized  controlled  trials.  The  results  from
ur  meta-analysis  showed  there  were  less  blood  loss  (WMD
lood loss =  −249.75  ml,  95%CI  −303.83  to  −195.67,  P <  0.0001)
nd  fewer  complications  (OR  =  0.40,  95%CI  0.23  to  0.70,
 =  0.001)  in  the  PFNA  group  compared  with  the  DHS  group.
owever,  there  was  no  difference  in  term  of  the  prognosis
etween  those  two  groups  (OR Mortality =  1.13,  95%CI  0.47  to
.69,  P  =  0.79).
Signiﬁcant  heterogeneity  was  observed  between  the
ncluded  trials  for  intraoperative  blood  loss,  and  operation
ime.  This  heterogeneity  may  be  attributable  to  varia-
ion  in  the  skills  of  the  surgeons  and  the  different  types
f  peritrochanteric  fractures.  The  eligibility  criteria  for
nclusion  of  patients  with  peritrochanteric  fractures  were
ifferent  from  each  other,  which  might  inﬂuence  the  obvi-
us  consistency  of  effects  across  those  included  studies
nd  cause  the  between-study  heterogeneity  (Table  1).  To
nsure  uniformity  in  both  deﬁning  patients’  characteristics
or  peritrochanteric  fractures  and  deﬁning  outcome  meas-
res,  an  individual  patient  data  meta-analysis  is  needed
32].  Besides,  we  did  not  undertake  a  subgroup  analy-
is  for  different  fracture  types  to  identify  the  possible
ource  of  heterogeneity  because  not  all  of  the  included
tudies  described  data  according  to  the  different  fracture
ypes.  Besides,  the  effects  might  differ  as  the  differ-
nt  fracture  types,  and  this  different  effect  need  further
tudy.
The  clinical  outcomes  of  different  DHS  were  different
33],  but  we  did  performed  subgroup  analyses  by  DHS  type
wing  to  the  limited  studies  reported  in  original  papers
Table  1).  Thus,  further  studies  can  compare  PFNA  and  DHS
n  account  of  the  different  type  of  DHS  independently.
esides,  one  main  outcome  in  this  meta-analysis  were  ana-
yzed  to  assess  the  efﬁcacy  of  PFNA  was  mortality.  As  to
he  mortality,  the  outcome  from  this  meta-analysis  showed
here  was  no  difference  in  term  of  the  prognosis  between
hose  two  group  (OR Mortality =  1.13,  95%CI  0.47  to  2.69,
 =  0.79).  Besides,  most  of  the  mean  durations  of  follow-
p  were  no  more  than  24  months,  which  was  too  shorter  to
ssess  the  effects  of  long-term  period  effectively  (Table  1).
hus,  the  effects  of  long-term  period  need  further  study,
specially  the  effect  on  the  mortality.
Established  surgical  options  for  peritrochanteric  frac-
ures  mainly  include  DHS,  Gamma  nail,  and  proximal
emoral  nail,  but  the  optimal  treatment  choice  contin-
es  to  be  highly  debated  [30,31,33—36].  The  PFNA  is  an
ntramedullary  device  with  a  helical  blade  rather  than  a
crew  for  better  purchase  in  the  femoral  head  and  has
een  adopted  for  patients  with  unstable  peritrochanteric
ractures  [5—7].  Our  meta-analysis  suggests  PFNA  can  bene-
t  peritrochanteric  fractures  patients  with  less  blood  loss
nd  fewer  complications  compared  with  DHS,  thus  PFNA
an  achieve  better  efﬁcacy  for  peritrochanteric  fractures
ompared  with  DHS.  In  addition,  there  are  several  estab-
ished  surgical  options  for  peritrochanteric  fractures,  but
hich  is  the  most  optimal  treatment  choice  continues  to
e  unclear.  Because  the  number  of  trials  directly  comparing
ifferent  surgical  options  is  limited,  a  network  meta-analysis
or  indirect  comparisons  needs  performing  to  provide  a
[L.  Shen  et  al.
omprehensive  assessment  of  different  surgical  options  for
eritrochanteric  fractures  [37].
In  conclusion,  PFNA  can  beneﬁt  peritrochanteric  frac-
ures  patients  with  less  blood  loss  and  fewer  complications
ompared  with  DHS.  However,  In  addition,  more  powered
andomized  studies  are  needed  to  identify  the  ﬁndings  from
his  meta-analysis,  and  the  effects  of  long-term  period  also
eed  further  study,  especially  the  effect  on  the  mortality.
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